In this study, given the importance of HP-PPIs and the potential differences between the HPV types most prevalent in cervical cancer (i.e., HPV16 and HPV18), a novel systems biology pipeline was used to develop efficient host-specific drug candidates against cervical cancer. Here, HP is linked to cervical carcinoma.